“…The pooled specificities across the studies were 0.78 (95% CI, 0.71-0.83), 0.82 (0.75-0.86), 0.74 (0.62-0.83), and 0.58 (0.48-0.67) for all AC, CTAC, RAC, and all NAC, respectively, when diagnosing CAD at a patient level; 0.81 (0.75-0.86), 0.82 (0.72-0.89), 0.80 (0.76-0.84), and 0.79 (0.70-0.85) for all AC, CTAC, RAC, and all NAC when detecting LAD stenosis; 0.91 (0.83-0.95), 0.89 (0.76-0.96), 0.92 (0.83-0.96), and 0.86 (0.76-0.92) for all AC, CTAC, RAC, and all NAC when detecting LCX stenosis; and 0.87 (0.82-0.91), 0.88 (0.79-0.93), 0.87 (0.82-0.90), and 0.61 (0.51-0.71) for all AC, CTAC, RAC, and all NAC when detecting RCA stenosis. The pooled DORs, which are regarded as being minimally affected by verification bias, were 16 (11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24), 15 (10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22), 16 , and 8 (6-12) for all AC, CTAC, RAC, and all NAC, respectively, when diagnosing CAD at a patient level; 13 (9-20)s, 15 (9-26), 11 (6-21), and 9 (6-13) for all AC, CTAC, RAC, and all NAC when detecting LAD stenosis; 18 (10-32), 15 , 20 , and 11 (6-20) for all AC, CTAC, RAC, and all NAC when detecting LCX stenosis; and 18 (11-29), 18 (9-36), 19 (10-37), and 7 (5-10) for all AC, CTAC, RAC, and all NAC when detecting RCA stenosis.…”